MARKET

SMMT

SMMT

Summit Therapeutics Inc
NASDAQ
18.31
-0.50
-2.66%
After Hours: 18.31 0 0.00% 19:36 12/05 EST
OPEN
18.88
PREV CLOSE
18.81
HIGH
19.10
LOW
18.08
VOLUME
2.44M
TURNOVER
--
52 WEEK HIGH
36.91
52 WEEK LOW
15.55
MARKET CAP
13.63B
P/E (TTM)
-14.7447
1D
5D
1M
3M
1Y
5Y
1D
Summit Therapeutics Grants Stock Options to New Employees
Reuters · 2d ago
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Barchart · 2d ago
Biotech Alert: Searches spiking for these stocks today
TipRanks · 3d ago
Citi Keeps Their Buy Rating on Summit Therapeutics (SMMT)
TipRanks · 4d ago
Small Caps Rally, Natural Gas Prices Jump To 3-Year Highs: What's Moving Markets Wednesday?
Benzinga · 4d ago
Weekly Report: what happened at SMMT last week (1124-1128)?
Weekly Report · 6d ago
Short Report: Sezzle short interest at record high
TipRanks · 11/30 16:30
Summit SMMT Q3 2025 Earnings Call Transcript
NASDAQ · 11/27 23:00
More
About SMMT
Summit Therapeutics Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of patient, physician, caregiver and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. Its lead development candidate is ivonescimab, a novel, potential first-in-class bispecific antibody intending to combine the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects of an anti-VEGF compound into a single molecule. Ivonescimab is being developed by both Akeso and the Company in multiple Phase III clinical trials. It is also developing ivonescimab in non-small cell lung cancer and other solid tumor settings. Ivonescimab is approved in China in combination with chemotherapy for patients with EGFR-mutated non-small cell lung cancer whose tumors have progressed following an EGFR-TKI based on the results of the HARMONi-A clinical trial.

Webull offers Summit Therapeutics Inc stock information, including NASDAQ: SMMT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SMMT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SMMT stock methods without spending real money on the virtual paper trading platform.